COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #107 of 231
8/8 Late treatment study
Lopez et al., Int. J. Antimicrob. Agents, doi:/j.ijantimicag.2020.106136 (Peer Reviewed)
Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results
Source   PDF   Share   Tweet
Small retrospective study of 29 ICU patients comparing those with HCQ plasma concentration within target to those with a concentration below the target value, with no significant differences found. Mortality in the on-target group was 0% versus 17% for the off-target group, mortality relative risk 0.14, p = 0.16.

Lopez et al., 8/8/2020, peer-reviewed, 8 authors.
Details of all 231 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit